OptimizeRx(NASDAQ) OPRX

Current Price$6.24

Market Cap$117.09M

Since IPO (2005)-98%

5 Year-88%

1 Year-55%

1 Month+32%

OptimizeRx last closing stock price
Metric	Price	Date
Last close	USD 6.24	2026-07-24

OptimizeRx stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-6.73%	USD 6.69	2026-07-17
1 month	+31.65%	USD 4.74	2026-06-24
3 month	-2.95%	USD 6.43	2026-04-24
Year to date	-49.1%	USD 12.26	2025-12-31
1 year	-55.24%	USD 13.94	2025-07-24
3 year	-55.08%	USD 13.89	2023-07-25
5 year	-88.41%	USD 53.86	2021-07-23
Since inception	-97.55%	USD 255.00	2005-08-08

OptimizeRx Financials at a Glance

Market Cap

$117.09M

Revenue (TTM)

$107.35M

Net Income (TTM)

$6.84M

EPS (TTM)

$0.35

P/E Ratio

17.67

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$6.24

Volume

13,662

Open

$6.21

Price

$6.24

Volume

13,662

Open

$6.21

Previous Close

$6.24

Daily Range

$6.18 - $6.30

52-Week Range

$4.54 - $22.25

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$6.24

Volume

13,662

Open

$6.21

Previous Close

$6.24

Daily Range

$6.18 - $6.30

52-Week Range

$4.54 - $22.25

Estimated Earnings Date

Aug 6, 2026

OPRX News

Page 1

OPRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OptimizeRx

OptimizeRx Corporation is a healthcare technology company that enhances digital communication between life sciences brands, healthcare providers (HCPs), and patients. Founded in 2006, the company offers a proprietary platform that integrates with electronic health record systems to deliver vital messages including financial assistance, support programs, and educational information. Their services are designed to improve treatment adherence and patient outcomes.

Products and Services

Dynamic Audience Activation Platform (DAAP): Uses predictive analytics to engage HCPs and patients precisely.

Micro-Neighborhood Targeting (MNT): A privacy-driven approach to direct-to-consumer marketing by targeting geographies based on patient data.

Profiler: Audience profiling to maximize marketing engagement and effectiveness.

Pharmacy Alerts: Real-time updates on pharmacy availability of medications.

Financial Messaging: Provides prescribers visibility to copay offers integrated into EHR systems.

What Makes OptimizeRx Corporation Special

OptimizeRx stands out with its AI-enabled platform that fosters effective communication between healthcare stakeholders. Its integration with health record systems and focus on privacy-centric targeting underscore its innovative approach in the digital health landscape.

Five Things You Need to Know

Founded in 2006, OptimizeRx has a history of pioneering digital solutions for patient and HCP engagement.

Its technology platform, integrated with EHRs, offers omnichannel marketing solutions for life sciences brands.

The company aims to be a "Rule of 40" entity, balancing high growth with profitability.

The acquisition of Medicx Health expands its capabilities to include comprehensive direct-to-consumer marketing.

OptimizeRx holds multiple patents, reinforcing its unique market position in digital health communications.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

133

CEO

Stephen L. Silvestro

Website

www.optimizerx.com

Headquarters

Waltham, MA 02453, US

OPRX Financials

Key Financial Metrics (TTM)

Gross Margin

69.05%

Operating Margin

13.57%

Net Income Margin

6.37%

Return on Equity

5.47%

Return on Capital

7.81%

Return on Assets

4.09%

Earnings Yield

5.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$117.09M

Shares Outstanding

18.77M

Volume

13.66K

Avg. Volume

437.46K

Financials (TTM)

Gross Profit

$74.12M

Operating Income

$14.57M

EBITDA

$18.90M

Operating Cash Flow

$14.38M

Capital Expenditure

-$52.00K

Free Cash Flow

$14.33M

Cash & ST Invst.

$20.17M

Total Debt

$23.72M

OptimizeRx Performance Analysis

OptimizeRx annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 62,450,156	1.9%
2023	2023-12-31	USD 71,521,506	14.5%
2024	2024-12-31	USD 92,127,000	28.8%
2025	2025-12-31	USD 109,429,000	18.8%

OptimizeRx sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	33.1%
Q3	2025-09-30	-10.7%
Q4	2025-12-31	23.7%
Q1	2026-03-31	-38.4%

OptimizeRx annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.64	N/A
2023	2023-12-31	USD -1.03	59.5%
2024	2024-12-31	USD -1.10	7.2%
2025	2025-12-31	USD 0.27	N/A

OptimizeRx sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	167.2%
Q3	2025-09-30	-50.4%
Q4	2025-12-31	550.0%
Q1	2026-03-31	-110.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$19.84M

-9.5%

Gross Profit

$13.87M

+3.9%

Gross Margin

69.89%

N/A

Market Cap

$117.09M

N/A

Market Cap/Employee

$880.41K

N/A

Employees

133

N/A

Net Income

-$495.00K

+77.5%

EBITDA

$1.58M

+276.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$20.17M

+21.7%

Total Debt

$23.72M

-27.7%

Accounts Receivable

$32.86M

+0.1%

Inventory

$0.00

N/A

Long Term Debt

$21.54M

-26.6%

Short Term Debt

$2.18M

-36.7%

Return on Assets

4.09%

N/A

Return on Invested Capital

9.29%

N/A

Free Cash Flow

-$488.00K

-112.7%

Operating Cash Flow

-$467.00K

-112.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NAKANakamoto Inc.

NAKANakamoto Inc.$4.87-2.01%

DHDefinitive Healthcare Corp.

DHDefinitive Healthcare Corp.$0.68-0.42%

RXSTRxSight, Inc.

RXSTRxSight, Inc.$5.19-3.35%

SPOKSpok Holdings, Inc.

SPOKSpok Holdings, Inc.$10.59+0.76%

SMLRSemler Scientific, Inc.

SMLRSemler Scientific, Inc.$20.33-4.87%

SLPSimulations Plus, Inc.

SLPSimulations Plus, Inc.$18.34+0.05%

SOPHSOPHiA GENETICS S.A.

SOPHSOPHiA GENETICS S.A.$5.72-5.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

Questions About OPRX

What is the current price of OptimizeRx?

OptimizeRx is trading at $6.24 per share.

What is the 52-week range for OptimizeRx?

Over the past 52 weeks, OptimizeRx has traded between $4.54 and $22.25.

How much debt does OptimizeRx have?

As of the most recent reporting period, OptimizeRx reported total debt of $23.72M.

How much cash does OptimizeRx have on hand?

OptimizeRx reported $20.17M in cash and cash equivalents in its most recent financial results.

What is OptimizeRx’s dividend yield?

OptimizeRx does not currently have a dividend yield.

OptimizeRx(NASDAQ) OPRX

OptimizeRx Financials at a Glance

OPRX News

3 Small-Caps That Might Be Acquisition Candidates

2 Small Caps That Are Soaring in 2021

These 2 Telehealth Companies Should Unite

Could OptimizeRx Solve This Problem in the Pharma Industry?

Why Would Doctors Use OptimizeRx?

This Healthcare Tech Stock Wants to Cut Out the Middleman

2 Top Small-Cap Stocks to Buy in July

2 Biotech Stocks That Could Be Millionaire Makers

OPRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About OptimizeRx

Products and Services

What Makes OptimizeRx Corporation Special

Five Things You Need to Know

OPRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

OptimizeRx Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OPRX

What is the current price of OptimizeRx?

What is the 52-week range for OptimizeRx?

How much debt does OptimizeRx have?

How much cash does OptimizeRx have on hand?

What is OptimizeRx’s dividend yield?

Premium Investing Services